DIWALI DHAMAKA 2021 - India Infoline

Page created by Beverly Lucas
 
CONTINUE READING
DIWALI DHAMAKA 2021 - India Infoline
DIWALI
DHAMAKA

  2021
DIWALI DHAMAKA 2021 - India Infoline
Diwali Dhamaka Performance – Year 2020

                                                                      Reco Price    CMP      Dividend      P&L w/
  Sr No           Stock
                                                                         (`)         (`)        (`)     Dividend (%)
Large Caps
      1         Reliance Industries                                     1850       2627.4      0.0          42%
      2         Infosys                                                 1063       1719.8      0.0          62%
      3         ICICI Bank                                               444        759.3      0.0          71%
      4         HCL Technologies                                         814        1194        7           47%
      5Dr Reddy‘s Laboratories                                          4877       4637.45     18           -5%
Mid Caps
      6         Tube Investments of India                                668       1417.75      5          112%
      7         Apollo Tyres                                             143       221.05       1           55%
      8         Persistent Systems                                      1115       3871.9       5          247%
                JB Chemicals &
      9                                                                                        28
                Pharmaceuticals                                          983       1697.05                  73%
                Security & Intelligence
     10                                                                                        0.0
                Services (India)                                         383       474.05                   24%
                Avg. Return %                                                                               73%
                Nifty 50 Return %                                                                           49%

*Price as on 22nd October , 2021; # ABB India price adj. for APPSIL
                                                                                                                       2
DIWALI DHAMAKA 2021 - India Infoline
Sanjiv Bhasin Diwali Portfolio – Year 2020

                                                                     CMP
    Sr No          Stock                                                         % Allocation
                                                                      (`)
       1          Federal Bank                                       102                16.6
       2          Godrej Properties                                  2351               16.6
       3          NBCC                                               47.05              16.6
       4          ABCAPITAL                                          101                16.6
       5          IRB                                                300                16.6
       6         RBL Bank                                            211                 16.6
                 Portfolio Return %                                                     113%
                 Nifty 50 Return %                                                      49%

Market Guru Sanjiv Bhasin had recommended a Multibagger Portfolio during Diwali 2020.

We are glad to announce that the portfolio has given a return of 113%, outperforming Nifty 50 by 64%!

Note: The portfolio has been rebalanced 4 times since Diwali 2020.

                                                                                                   3
DIWALI DHAMAKA 2021 - India Infoline
Indian Equity Outlook

•   GST collection has been crossing average 1.2 lakh crore consistently in the last 6 months, revenue
    collection looks stable for the government.

•   With Covid-19 in the backdrop now and more than 100 Billion doses of Covid vaccines being
    administered, the focus would be back on growth sectors.

•   The MPC retained FY22 GDP forecast of 9.5% but raised 3Q GDP estimates from 6.3% to 6.8%. The
    governor noted growth impulses strengthening in the last 2 months, based on High Frequency indicators
    looking up.

•   Going forward, we believe a calibrated withdrawal of liquidity by the RBI is likely, especially as the
    inflation impulse from excess liquidity will start effecting as credit growth picks up.

                                                                                                         4
DIWALI DHAMAKA 2021 - India Infoline
Indian Equity Outlook

•   We believe that companies with robust business model, strong moat, resilient balance sheet will help
    the portfolio tide over the impending volatility which could be expected by the hike in the interest rates.

•   Investment cycles drive sustained economic growth, and the improving outlook on income would
    encourage household investment spending.

•   What can derail this stack of assumptions is if supply bottlenecks turn out to be so persistent that growth
    is obstructed and inflation becomes entrenched, thus creating stagflation. But, we believe chances are
    that this would be resolved over the next year.

                                                                                                                  5
TOP 10 STOCKS

RECOMMENDATIONS FOR
             2022

  Buy IIFL Diwali Dhamaka 2021   6
Diwali Dhamaka Stocks – Year 2021
                                                            Return
 Sr No       Stock                     CMP        Target               Weightage   Buy Now
                                                           Potential
 Large Caps
     1      ICICI Bank                795-822      940       16%         10%         Buy
     2      Infosys                  1675-1726    2080       22%          7%         Buy
     3      Tata Motors               470-493      610       27%          7%         Buy
     4      HDFC Bank                1570-1630    2000       25%          9%         Buy
     5      Larsen & Toubro          1780-1845    2192       21%          7%         Buy
     6  Tata Steel                   1260-1310    1897       48%          9%         Buy
 Mid Caps

     7                                                       12%          9%
            Tube Investments of India 1360-1410   1555                               Buy
     8      Deepak Nitrite           2190-2270    2890       30%          6%         Buy
     9      SWSOLAR                   400-422      750       82%          5%         Buy
    10     RSWM                       375-391      700       83%          5%         Buy
           Shriram Transport
    11                                                       23%         10%
           Finance                   1455-1510    1825                               Buy
           Persistent Systems
    12                                                       22%          9%
                                     3900-3990    4795                               Buy
           Tata Chemicals
    13                                                       28%          7%
                                      880-910     1150                               Buy

*Price as on October 28, 2021
                                 Buy IIFL Diwali Dhamaka 2021                                7
Large Caps

             8
ICICI Bank

       CMP: ₹795-822                 BUY                      TP: ₹940             Upside: 16%

•    ICICIBC reported a profit of Rs55.1bn in 2QFY22 with strong performance across metrics. Core PPOP
     grew 21% YoY. NII grew 7/25% QoQ/YoY to Rs117bn, driven by all-time high NIMs of 4% and strong
     loan growth of 17% YoY.
•    Core fees grew 18%/21% QoQ/YoY. Provisions came in at Rs27bn as ICICIBC did not utilise
     contingency provisions. GNPA ratio declined 39bps QoQ to 5.1% owing to negligible net slippages.
•    NIM increased on both, YoY and QoQ basis, aided by the decline in cost of funds which had a larger
     impact than the decline in yield on funds.
•    Loan growth remained robust at 17% YoY (same as 1QFY22). Domestic loan growth was marginally
     lower at 19% YoY (20% YoY in 1QFY22). Growth was driven by retail loans (+22% YoY) and SME loans
     (+41% YoY).
•    We increase NIM estimates 10-15bps, leading to 3-5% increase in NII. Continued momentum in retail
     and SME business should keep fee-income growth healthy. On the back of buoyancy in core income,
     we expect ICICIBC to accelerate on opex, to invest in its franchise and tech.

    Financial Summary

     Consolidated (`bn)   Revenue     CAR (%)       EPS (`)     EPS growth (%)   P/E (x)     RoE (%)

    FY22E                  188.0        19.1          33.0           41.0         16.9         14.7

    FY23E                  218.3        18.3          39.0           18.1         14.3         15.5
                                                                                                          9
Infosys

      CMP: ₹1675-1726                    BUY                    TP: ₹2,080              Upside: 22%

•    Infosys is a leading provider of consulting, technology, outsourcing and next-generation digital services,
     enabling clients to execute strategies for their digital transformation.
•    Broad based growth as Infosys reported US$ revenue of 4bn, a growth of +6.3% cc QoQ/+19.4% cc YoY
     − the fastest YoY revenue growth in 11 years.
•    Led by strong deal wins of US$2.15bn in 2QFY22 (37% net new; TTM +67% YoY), a robust demand
     environment and the healthy deal pipeline, Infosys has raised its FY22 revenue growth guidance for a
     second time in the fiscal, ranging at 16.5-17.5% cc YoY (from 14-16% cc YoY earlier).
•    Of the 22 large deals signed this quarter, 5 are in the BFSI space.
•    It retained margin guidance of 22-24%. We believe this adequately factors in potential headwinds,
     including reduction in cost savings from travel, higher subcontracting and skill-based wage hikes from 1-
     Oct.
•    We believe Infosys will continue delivering industry leading growth among large caps which warrants
     convergence of its valuation gap with TCS. We believe consistent earnings delivery ensures that it will
     become a core portfolio-holding for FIIs, after a decade of trading at a discount to TCS.
    Financial Summary
                                      EBITDA
     Consolidated (`mn)   Revenue                EPS (`)   EPS growth (%)    P/E (x)   RoE (%)   RoCE (%)
                                      Margin

    FY22E                 1,195,235   26.5%        53.3          15.8         32.1      29.7       40.5

    FY23E                 1,382,785    26.3        62.3          17.0         27.4      33.5       45.6

                                                                                                             10
Tata Motors

       CMP: ₹470-493                  BUY                     TP: ₹610               Upside: 27%

•   Tata Motors Group is a leading global automobile manufacturer.
•   TTMT has taken the lead in this nascent market, with ~70% market-share. Some of the factors that are
    aiding higher EV penetration are government incentives, launch of relatively affordable models, rise in
    ICE vehicle prices, sharp rise in fuel costs, etc.
•   TTMT’s planned passenger car EV subsidiary (‘EVCo.’) will be asset-light and would house all dedicated
    EV talent and design capabilities. ‘EVCo.’ would invest USD2bn over the next five years in products,
    platforms, charging infrastructure, etc.
•   TTMT aims to take the lead in accelerating EV adoption of the industry. Management targets EVs
    contributing 20% of its PV volumes in the next 5 years, by offering wider India specific products with
    different body styles and driving ranges.
•   Plans to launch EV models by FY26. The growth potential is high, with demand/bookings outpacing
    supply (large order backlog).
•   Tata Group will provide the overall eco-system, namely Tata Power for EV charging infra, Tata Motors
    Finance for financing, TCS/Tata Elxsi for ADAS and technology, Tata AutoComp for battery assembly
    plant, Tata Chemicals for Li-ion cell manufacturing and battery recycling.
    Financial Summary
     Consolidated                 EBITDA
                      Revenue                 EPS (`)   EPS growth (%)   P/E (x)   RoE (%)   RoCE (%)
    (`mn)                         Margin

    FY22E             2,850,192     10.2        (9.5)         -          (44.2)       -          -

    FY23E             3,809,014     13.8        35.7          -           11.8        -          -
                                                                                                         11
HDFC Bank

      CMP: ₹1570-1630                       BUY                       TP: ₹2000                  Upside: 25%

•   HDFC Bank is the largest private sector bank in India with a market share of ~10.3% in system loans as of FY21. It
    has a strong national network of 5,608 branches spread across urban and rural markets, a high-quality deposit
    franchise, well-diversified revenue mix, strong asset quality, and consistent financial performance.
•   We see some greenshoots of high yielding retail/SME loan growth improving and asset quality stabilizing , giving
    room to HDFC Bank to invest in tech and franchise in a highly competitive environment.
•   NIMs stable QoQ at 4.1% , Fees (incl. forex income) grew 14/29% QoQ/YoY and Opex grew 14/15% QoQ/YoY led
    by additional ESOP prov. of Rs830mn.
•   GNPA ratio in the corporate segment is low at 0.55% reflecting strong asset quality, while it is also low in the retail
    segment at 1.37% driven by stronger underwriting.
•   HDFC Bank continued to scale-up its branch network in 2QFY22, adding 33 branches. Further, ~400 branches are
    in various stages of readiness and would be opened shortly.
•   Credit card spends grew 36% YoY and 27% QoQ in the quarter. The ban on issuance of new credit cards was lifted
    by the RBI on August 18, 2021 post which they issued ~416k cards in the last 5 weeks of 2QFY22 which they
    expect to sustain.
•   We expect trend to improve going forward. Best-in-class CAR of ~20% and CET 1 of ~17.4% shall ensure dilution-
    free growth ahead, and liquidity levels should help the Bank. ROA/ROE is expected to be best in class at ~2/18%.
     Financial Summary

       Consolidated (`bn)      Revenue        CAR (%)          EPS (`)      EPS growth (%)       P/E (x)       RoE (%)

     FY22E                      1040.7           19.2            66               17.5            25.4           16.7

     FY23E                      1208.0           19.4            78               18.2            21.5           17.3
                                                                                                                         12
Larsen and Toubro

      CMP: ₹1780-1845                 BUY                       TP: ₹2192             Upside: 21%

•    L&T is India’s largest engineering and construction company with no real peers when compared on
     breadth and depth of offerings.
•    On the back of strong sector tailwinds and outperformance of L&T’s listed IT subsidiaries (LTI, LTTS,
     MTCL) driving an earnings upgrade, we raise consol. EPS for L&T by 4/6/5% for FY22/23/24. Value of
     listed subs has increased to Rs1,062/sh (vs Rs727 in Aug21), now contributing to 48% of the share in
     L&T’s SOTP valuation, up from 40% in Aug-21
•    Normalcy in business operations, expects execution and orders to accelerate in 2H to deliver a mid-
     teen growth in FY22.
•    L&T group aims to invest in implementation of green energy in manufacturing and construction sites
     and also offer solutions to customers in areas such as hydrogen, decarbonisation, bio-fuels in its
     journey of energy transition.
•    Pick up in execution, expertise in managing costs, improving NWC cycle and balance-sheet repair
     should aid 19% EPS CAGR (ex-services) in FY22-24. Core valuations are attractive at 13x FY23ii EPS.
     L&T now trades at 15x/13x FY22/23ii EPS (~10% cheaper vs Aug-21).

    Financial Summary
     Consolidated                       EBITDA
                          Revenue                     EPS (`)     EPS growth (%)   P/E (x)      RoE (%)
    (`mn)                               Margin

    FY22E                1,582,414       12.2          68.9            38.9          26.0         12.2

    FY23E                1,856,629       12.4          86.5            25.5          20.7         14.0
                                                                                                             13
Tata Steel

      CMP: ₹1260-1310                  BUY                       TP: ₹1897              Upside: 48%

•     Tata Steel is India’s second-largest private sector steel company. Established in 1907, it now boasts of
      19.6mtpa of finished steel capacity in India.
•     TSE’s NSR jump has lagged spot prices, as ~60% of volumes entail a six-monthly re-pricing.
      Management indicated a EUR200/t jump in NSR at TSE in 2Q, as contracts have reset at higher
      pricing. This should continue inching up if such steel prices sustain.
•     Combined with strength in India operations due to elevated steel prices, this drives 22%/15%
      upgrade to the FY22/23ii consolidated EBITDA.
•     Post a largely stable debt in 1Q, strong profitability combined with minimal further increase in
      working capital needs should drive strong deleveraging in FY22.
•     Tata Steel’s standalone EBITDA at Rs102.1bn (+11% QoQ) was largely in line with estimates.
      Standalone EBITDA/t expanded to a decade high of Rs35,570, aided by price hikes.
•     Domestic steel prices are at 20% discount to landed cost of imports which offers room for further
      prices hikes going forward, if demand is strong.

    Financial Summary
     Consolidated                        EBITDA
                          Revenue                      EPS (`)     EPS growth (%)     P/E (x)      RoE (%)
    (`mn)                                Margin

    FY22E                 2,323,093        29.1         342.1           380.1           4.3         44.9

    FY23E                 1,986,739        23.3         210.7           (38.4)          6.9         21.0
                                                                                                             14
Mid & Small Caps

                   15
Tube Investments

      CMP: ₹1360-1410                   BUY                    TP: ₹1555                Upside: 12%

•   As part of the large and diversified Murugappa Group, Tube Investment Holdings is a mobility-focused
    manufacturing company with a strong, established franchise across the auto and industrial sectors.
•   TI’s 3W electric foray is on track for launch in March ’22, with in-house manufacturing granting
    advantages of superior design, performance and service vs peers. Testing for 50k kms is complete, with
    encouraging results.
•   Subsequent plans include foray into electric 3Ws (cargo) as well as e-rickshaws next year, and electric 2Ws
    thereafter. TI has also launched an e-bike in Tamil Nadu during Jul-21 and expects to expand distribution
    to rest of India as well as via exports in coming months.
•   In the engineering and metal-formed business, traction in exports has been strong, with revenue share
    rising to 16-17% in 1QFY22 vs 8-9% earlier. This is largely driven by the engineering business and
    industrial chains. Bicycle exports should also double in FY22, as per management.
•   The company is also exploring opportunities in waste-to-energy, standalone power grids and medical
    devices.
•   Aluminium tube manufacturing as well as supply of motors from CG Power are being explored for EVs.

    Financial Summary
     Consolidated                     EBITDA
                          Revenue                  EPS (`)   EPS growth (%)   P/E (x)   RoE (%)    RoCE (%)
    (`mn)                             Margin

    FY22E                 101,842      11.6%        37.8         110.5         39.3       29.7       20.3

    FY23E                 118,570      12.2%        44.3          17.0         33.6       27.9       21.6
                                                                                                              16
Deepak Nitrite

      CMP: ₹2190-2270                     BUY                       TP: ₹2890                Upside: 30%

•   DNL's Basic Chemicals (BC) segment surprised, with further sharp improvement in margins (up +530bps QoQ) to
    34%. The company took advantage of the positive price trend across certain products
•   Demand for Fine & Speciality Chemicals continue to be strong.
•   The nitro business has a decent mix of large and small customers. The nitro business is also benefitting from the
    closure of capacities in China and the reluctance of European manufacturers to engage in hazardous chemistries.
•   The company is in the advanced stages of doubling the IPA plant capacity and also improving on the power utility
    costs (via a captive power plant). Management expects these projects to contribute from 3QFY22.
•   In terms of new capex, the company has announced a plan to invest Rs7bn into downstream products of phenol
    and acetone, namely new import-substitute solvents. DNL will invest Rs3bn in new chemistries like fluorination in
    order to expand specialty product lines.
•   DNL aims to select only those products in which the company could be among the top-3 global suppliers for the
    next 10- 15 years. The key focus areas in terms of end-use segments would be solvents, life science chemicals, and
    dyes & pigments.
•    Apart from growth projects, DNL is setting up a premium high-tech R&D centre. The company will make higher
    investments in R&D initiatives and launch new products in coming years.

     Financial Summary
      Consolidated                        EBITDA
                            Revenue                    EPS (`)   EPS growth (%)    P/E (x)    RoE (%)     RoCE (%)
     (`mn)                                Margin

     FY22E                   59,945       15,443        72.3          27.2          29.1        35.3        40.40

     FY23E                   66,404       17,318        84.1          16.2          25.1        30.4        36.4
                                                                                                                     17
SW Solar

        CMP: ₹400-422                    BUY                       TP: ₹750              Upside: 82%

•   Sterling and Wilson Solar Ltd is one of the leading end-to-end solar engineering, procurement and
    construction (EPC) solutions providers globally and is also engaged in the operation and maintenance (O&M)
    of solar power projects. The company is backed by strong parentage of the Shapoorji Pallonji Group (SP
    Group)
•   Reliance Energy has made an open offer @375 to acquire 40%, which heralds the group into solar energy
    with the company being the biggest solar panel maker in the world. Also, it is the country' largest player in
    MEP & EPC execution with debt being paid off by past promoters.
•   Order inflow till date at Rs473cr (623 MW) with 8.7 GW contracted O&M as on date. Gross Un-execute
    Order Value (UOV) as at date is Rs 8,731 cr. Management is focusing on to target large markets like North
    America & Europe with combined size over 26.5 GW in CY21.
•   Due to the impact caused by the increase in module and commodity prices, adjusted gross margins in Q1FY22
    continue to remain suppressed for ongoing project.

    Financial Summary

     Consolidated (`bn)     Net income   PAT Margin      EPS (`)      EPS growth (%)   P/E (x)      RoE (%)

    FY22E                     54,365           4%          3.40               -          31          22.84

    FY23E                     59,257           5%         11.08            36%           22.7       28.03%
                                                                                                              18
RSWM
         CMP: ₹375-391                      BUY                  TP: ₹700                 Upside: 83%

•   RSWM Limited is engaged in the manufacturing, spinning, weaving and processing of man made textile
    fabrics. The company is also engaged in cotton spinning and weaving. Its segment includes Yarn, and Fabric
    & Denim. RSWM is the Largest yarn maker with popular brand "Mayur" doing extremely well. It is also one
    of the largest makers of denim supplying to "Levi' Calvin Klein & Wrangler.
•   The company has been able to manage operations at full capacity through out the period of restrictions.
    Q1FY22 has ended with total revenues at Rs750cr and PAT of Rs37cr.
•   Debts slightly increased as compared to 31st March due to increased working capital utilization on account
    of stock of cotton & increased volume of business. Debt is mostly from hydro & solar power plants which is
    in state partnerships & which are now doing very well which will see reduction in debt & improvement in
    ROE.
•   Company’s manufacturing units are operating at normal capacity. Inventories are under control. Increased
    penetration of organized retail, favorable demographics and rising income level will drive demand of Textiles
    in the future Pandemic has led to an increased demand for Technical Textiles also.
•   As 100% FDI is allowed (automatic route), PLI of Rs10,683cr (USD 1.44 billion) for man made fiber and
    Technical Textiles, support to hand loom weavers under MUDRA Scheme will led to the growth in the top l&
    bottom line of the company
      Financial Summary

       Consolidated (`mn)       Net income        PAT Margin     EPS (`)        P/E (x)      RoE (%)

     FY22E                         25,586            2.0%         21.7           16.9          6%

     FY23E                         28400             3.0%         36.2          10.14          9%
                                                                                                              19
Shriram Transport Finance

      CMP: ₹1455-1510                  BUY                    TP: ₹1825             Upside: 23%
•   Shriram Transport Finance is the largest financer of CVs in India. The company enjoys a large
    market share of ~25% in the used-CV financing market and ~6% in the new-CV financing
    segment. With focus on a particular set of customers − small-truck owners − who do not have
    access to bank financing, SHTF has developed a unique ‘close-to-the-customer’ model over the
    past 30 years.
•   Management is in the process of evaluating mergers within the group companies.
•   Shriram Transport Finance’s Disbursement in the 1QFY22 was a positive surprise as it was 4%
    higher than the pre-Covid levels driven by pent-up demand in PV and LCV segment along with
    sanctions from previous quarters.
•   With economic activities resuming post Covid-19, we can expect normal provisioning from 3QFY22
    as collection and recoveries would improve.
•   The company has excess liquidity on its balance sheet, and this was leading to excess negative
    carry. The management plans to reduce the excess liquidity which can tackle this negative carry
    and increase margins.

    Financial Summary

     Consolidated (`bn)   Net income   PAT Margin   EPS (`)      EPS growth (%)   P/E (x)   RoE (%)

    FY22E                    89.2        30.5%      108.2             10%         14.09      11%

    FY23E                   101.4        32.0%      123.8             14%         12.32     10.56%
                                                                                                      20
Persistent Systems

      CMP: ₹3900-3990                   BUY                     TP: ₹4795                Upside: 22%
•   The company’s focus is on helping clients build and manage software-driven businesses.
•   Its business strategy is aligned around four key areas: (A) Digital: Bringing together their technology
    partner ecosystem, solutions and a unique architecture to enable digital transformation, (B) Alliance:
    Focus on long-standing and multidimensional relationship between PSYS and IBM, (C) Services: Focus on
    services for software and product development including agile and experience design, (D) Accelerite:
    Focus on products that include business-critical infrastructure software for enterprises, telecom operators
    and public sector.
•   Their focus on penetrating sub-segments of Healthcare is yielding results and, given their strong
    positioning in the Instrumentation/Medical devices sub segment and Salesforce capabilities for the
    Provider market, the outlook remains robust.
•   2Q margin at 13.9% were above estimates, despite full impact of wage hikes during the quarter.
•   In the past 3 quarters, PSYS has won deals worth 114% of FY21 revenues, executable in the next 12
    months. Its headcount grew 47% yoy and is a key leading indicator of FY22 growth. A combination of
    improved revenue visibility (29% CAGR in FY21- 23ii) and steady margin improvement over the next two
    years will drive 39% EPS CAGR over FY21-23ii.

     Financial Summary
      Consolidated                     EBITDA
                           Revenue                  EPS (`)   EPS growth (%)   P/E (x)   RoE (%)    RoCE (%)
     (`mn)                             Margin

     FY22E                  52,805       16.9        89.6          51.9         33.9       23.0       30.8

     FY23E                  62,317       17.3       109.6          22.4         27.7       24.8       33.1
                                                                                                               21
Tata Chemicals

       CMP: ₹880-910                   BUY                     TP: ₹1150               Upside: 28%
•   Tata Chemicals Ltd. (TCL) operates principally in industrial, agricultural and consumer chemicals. The
    company is among the world's top manufacturers of soda ash with annual production capacity in excess
    of 4m tons spread across four continents.
•   More than 70% of TCL's soda ash capacity is based on low-cost natural sources, giving the company a
    sustainable competitive advantage relative to synthetic soda ash manufacturers. In addition, the company
    has a presence in India's agricultural inputs industry by virtue of its majority ownership stake in Rallis
    India, which manufactures agrochemicals and seeds.
•   The outlook for soda ash has markedly improved in recent months, with sharp price increases announced
    in India as well as the US. This should drive margin improvement in coming quarters. soda ash itself is
    consumed in significant quantities to manufacture lithium-ion batteries, and this will be an important
    demand driver in coming years.
•   Soda ash spot prices are already up, but contracted prices are still below pre-COVID levels. Pricing
    contracts in the US and UK markets are renewed annually and will be reset in Dec-2021; that is when the
    benefits of the market tightness will show up in financials.
•   Nutraceuticals business seems to be gaining traction, with recent customer order wins. The outlook for
    salt and bicarbonate is also positive, while IMACID profits too have vaulted
    Financial Summary
     Consolidated                     EBITDA
                         Revenue                  EPS (`)   EPS growth (%)   P/E (x)   RoE (%)   RoCE (%)
    (`mn)                             Margin

    FY22E                 123,543      19.5        46.2         359.1         17.8       8.0        7.7

    FY23E                1353,879      21.0        55.5          20.2         14.8       9.0        9.1
                                                                                                            22
Disclosure
Disclaimer:
Recommendation Parameters for Fundamental/Technical Reports:

Buy – Absolute return of over +10%
Accumulate – Absolute return between 0% to +10% Reduce – Absolute return
between 0% to -10%
Sell – Absolute return below -10%

Please refer to http://www.indiainfoline.com/research/disclaimer for recommendation parameter, analyst disclaimer and other disclosures.

Investments in securities market are subject to market risks, read all the related documents carefully before investing. There is no assurance
or guarantee that the investment objectives shall be achieved. IIFL does not guarantee any assured returns on the investments
recommended herein. Past performance of securities/ instruments is not indicative of their future performance. IIFL makes no
representation/s or warranty/ies, express s or implied, as to the accuracy, completeness or reliability of any information compiled herein,
and hereby disclaims any liability with regard to the same, including, without limitation, any direct, indirect, incidental or consequential loss.
You shall verify the veracity of the information on your own before using the information provided in the document. Investors are
requested to review the prospectus carefully and obtain expert professional advice. IIFL group, associate and subsidiary companies are
engaged in providing various financial services and for the said services (including the service for acquiring and sourcing the units of the
fund) may earn fees or remuneration.

IIFL Group | IIFL Securities Ltd., IIFL House, Sun Infotech Park, Road No. 16V, Plot No. B-23, MIDC, Thane Industrial Area, Wagle Estate, Thane -
400604. CIN: 99999MH1996PLC132983 Tel.: (91-22)2580 6650. Customer Service: 40071000.Stock Broker SEBI Regn: INZ000164132. NSE:
10975 BSE: 179 MCX: 55995 NCDEX: 01249 Depository: INDP1852016. MF Distributor ARN: 47791. PMS SEBI Regn,: INP000002213.
Investment
Adviser SEBI Regn. INA00000623. Research Analyst SEBI Regn: INH000000248. Loan products are offered by IIFL Finance Ltd. & IIFL Home
Finance Ltd. Kindly refer to www.indiainfoline.com for detailed disclaimer and risk factors.

                                                                                                                                                     23
Thank You
You can also read